GLP-1 agonists are generally considered low risk for hypoglycemia because their insulinotropic effects are glucose-dependent, tapering off as serum glucose approaches euglycemia
Educating patients about the potential effects of alcohol on blood glucose levels helps them understand the importance of consuming food along with alcohol to prevent hypoglycemia
This positions amycretin as a direct competitor to retatrutide, likely reaching market around the same time
Once absorbed, GLP-1 medications circulate throughout your entire body
Managing Side Effects Across Compounds Each compound in this stack brings its own potential side effect profile
Written in collaboration with Dr Samila Asad GP & NLP Coach, The Female Health Doctor Clinic After my recent post on microdosing GLP-1s , Ive had so many questions from women, both in clinic and online about how it really works, who its for, and what to expect